Canadian Marijuana Stocks Climb as Bill C-45 Receives Royal Assent

Patrick Smith | Analyst | Ubika Research | Patrick@UbikaResearch.com | 1 (647) 444-5506
Maxim Medvedev | Associate | Ubika Research | | max@ubikaresearch.com | 1 (647) 936-6692

The Ubika Marijuana 25 Index of Canadian marijuana stocks continues to outperform year over year

Ubika Marijuana 25 Index May 11, 2018 - July 6, 2018

UMJ25 -1.5% (166.5% Y/Y)

TSX-V: -5.2% (-1.5% Y/Y)

HMMJ: 4.7% (116.8% Y/Y)

Dollar amounts in CAD unless otherwise stated.

Top Volume Gainers (30D/30D)

The Ubika Marijuana 25 Index has fallen slightly since our last report dated May 14, 2018, easing 1.5%. However, the index outperformed the TSXV Index, which fell by 5.2% over the same period. Notable performers in this report include:

  1. Canopy Growth Corporation (TSX:WEED), which surged 21% as Bill C-45 received Royal Assent. This appeared to solidify WEED dominant position in the market.
  2. Aurora Cannabis Inc. (TSX:ACB), which jumped 23% following numerous synergistic acquisitions and the upcoming completion of the MedReleaf acquisition.

This Content is Exclusive to Our Members

Login below

To read our full disclosure, please click on the button below: